MHRA Appoints New Chief Executive
News Jul 05, 2013
He will take up the post in September when current Chief Executive Sir Kent Woods steps down, after ten years with the agency.
Dr Hudson is currently the MHRA’s Licensing Director, responsible for the majority of medicines licensing activities. He is the UK delegate to the Committee on Human Medicinal Products (CHMP) at the European Medicines Agency and has been its vice-chairman since October 2012.
In line with Government protocol, the Department of Health officially announced the appointment and their press release is available through the link below.
RELATED ARTICLES
Easily Automate PK Assays for Human IgG Drugs in Preclinical Species
NewsAt AAPS NBC event, Lumigen produced a poster summarizing the use of their pipetting robot, Andrew which can measure IgG drug concentration in a pre-clinical setting.
READ MORE
Could This Be a "Silver Bullet" for Preventing and Treating Colon Cancer?
NewsA team of scientists targeted the gene CtBP with a drug known as HIPP (2-hydroxy-imino phenylpyruvic acid) and were able to reduce the development of pre-cancerous polyps by half.
READ MORE
Ingestible Drug-Delivery Materials May Improve Patient Treatment Compliance
NewsHydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.
READ MOREComments | 0 ADD COMMENT
Like what you just read? You can find similar content on the communities below.
Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
6th Edition of International Conference on Pharmacognosy and Medicinal Plants
Apr 16 - Apr 17, 2018
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017
Login
You must be logged in to post a comment.